$0.6818
0.046.61%
At close: -
$0.8392
0.1623.09%
After Hours: 7:59 PM EDT
Prelude Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Prelude Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PRLD | Prelude Therapeutics | -$0.42 | -$0.44 | — | — | $0.00 | — | — | — | 05/06/2025 | Get Alert |
PRLD | Prelude Therapeutics | -$0.45 | -$0.47 | -$0.37 | 21.28% | $0.00 | — | $4.00M | — | 03/10/2025 | Get Alert |
PRLD | Prelude Therapeutics | -$0.45 | -$0.47 | -$0.43 | 8.51% | $0.00 | — | $3.00M | — | 11/06/2024 | Get Alert |
PRLD | Prelude Therapeutics | -$0.54 | -$0.42 | -$0.46 | -9.52% | $0.00 | — | $0.00 | — | 08/12/2024 | Get Alert |
PRLD | Prelude Therapeutics | -$0.58 | -$0.48 | -$0.42 | 12.50% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
PRLD | Prelude Therapeutics | -$0.60 | -$0.49 | -$0.45 | 8.16% | $0.00 | — | $0.00 | — | 02/15/2024 | Get Alert |
PRLD | Prelude Therapeutics | -$0.63 | -$0.58 | -$0.45 | 22.41% | $0.00 | — | $0.00 | — | 11/01/2023 | Get Alert |
PRLD | Prelude Therapeutics | -$0.58 | -$0.63 | -$0.54 | 14.29% | $0.00 | — | $0.00 | — | 08/03/2023 | Get Alert |
PRLD | Prelude Therapeutics | -$0.63 | -$0.68 | -$0.58 | 14.71% | $0.00 | — | $0.00 | — | 05/08/2023 | Get Alert |
PRLD | Prelude Therapeutics | -$0.71 | -$0.63 | -$0.60 | 4.76% | $0.00 | — | $0.00 | — | 03/15/2023 | Get Alert |
PRLD | Prelude Therapeutics | -$0.66 | -$0.64 | -$0.63 | 1.56% | $0.00 | — | $0.00 | — | 11/14/2022 | Get Alert |
PRLD | Prelude Therapeutics | -$0.58 | -$0.65 | -$0.58 | 10.77% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
PRLD | Prelude Therapeutics | -$0.47 | -$0.65 | -$0.63 | 3.08% | $0.00 | — | $0.00 | — | 05/10/2022 | Get Alert |
PRLD | Prelude Therapeutics | -$0.45 | -$0.68 | -$0.71 | -4.41% | $0.00 | — | $0.00 | — | 03/16/2022 | Get Alert |
PRLD | Prelude Therapeutics | -$5.25 | -$0.62 | -$0.66 | -6.45% | $0.00 | — | $0.00 | — | 11/12/2021 | Get Alert |
PRLD | Prelude Therapeutics | -$5.50 | -$0.49 | -$0.58 | -18.37% | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
PRLD | Prelude Therapeutics | — | -$0.46 | -$0.47 | -2.17% | — | — | $0.00 | — | 05/11/2021 | Get Alert |
PRLD | Prelude Therapeutics | — | — | -$0.45 | — | — | — | $0.00 | — | 03/16/2021 | Get Alert |
PRLD | Prelude Therapeutics | -$3.93 | — | -$5.25 | — | $0.00 | — | $0.00 | — | 11/10/2020 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-10 | $-0.37 | $-0.47 | 21.3 % |
Q3 | 2024-11-06 | $-0.43 | $-0.47 | 8.51 % |
Q2 | 2024-08-12 | $-0.46 | $-0.42 | -9.52 % |
Q1 | 2024-05-07 | $-0.42 | $-0.48 | 12.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Prelude Therapeutics (PRLD) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
The Actual EPS was $-0.37, which beat the estimate of $-0.47.
The Actual Revenue was $4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.